Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 113.61B | 12.91%113.54B | -4.93%450.99B | -15.20%116.33B | -20.24%100.56B | -24.57%474.36B | -38.54%99.1B | -31.69%112.01B | -14.07%137.18B | -12.48%126.07B |
| Cost of revenue | 75.45B | 11.26%68.44B | -4.51%278.69B | -16.98%71.44B | -16.62%61.51B | -19.66%291.85B | -32.72%63.16B | -26.46%68.87B | -7.14%86.05B | -11.19%73.77B |
| Gross profit | 38.16B | 15.50%45.1B | -5.60%172.3B | -12.20%44.89B | -25.35%39.04B | -31.29%182.52B | -46.65%35.94B | -38.65%43.15B | -23.65%51.13B | -14.23%52.3B |
| Operating expense | 29.72B | 13.00%28.96B | 8.45%107.22B | 8.42%27.36B | 5.49%25.62B | 2.46%98.86B | -1.66%24.37B | 1.24%24.97B | 4.71%25.23B | 5.87%24.29B |
| Operating profit | 8.44B | 20.27%16.14B | -22.20%65.09B | -32.29%17.54B | -52.08%13.42B | -50.55%83.65B | -72.84%11.57B | -60.19%18.18B | -39.60%25.9B | -26.36%28.01B |
| Net non-operating interest income (expenses) | 4.16B | -22.36%4.58B | 14.12%22.7B | 37.60%6.08B | 52.55%5.9B | 241.13%19.89B | 105.37%6.27B | 212.22%5.34B | 506.46%4.42B | 1,037.35%3.87B |
| Non-operating interest income | --4.18B | -21.99%4.61B | 13.51%22.82B | 36.82%6.12B | 50.54%5.91B | 235.87%20.1B | 103.70%6.33B | 208.79%5.38B | 485.47%4.47B | 952.01%3.92B |
| Non-operating interest expense | --26M | 250.00%28M | -44.55%117M | -22.41%45M | -85.96%8M | 37.01%211M | 9.26%59M | 19.35%37M | 61.11%58M | 72.73%57M |
| Net investment income | 3.43B | -156.35%-5.36B | 1,254.87%12.94B | -60.35%3.93B | 432.87%9.51B | -75.92%955M | 43.33%-9.89B | -64.36%3.78B | 0.03%9.92B | -421.73%-2.86B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -1.04B | 0 | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -121M | 88.33%-7M | 99.60%-80M | 97.64%-3M | 69.39%-60M | -745.93%-19.93B | -324.11%-2.02B | -13,426.15%-17.58B | 80.34%-127M | 82.23%-196M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | -94.27%80M | ---- | ---- | -13.99%1.4B | 20.03%1.4B | ---- | ---- | ---- |
| Less:Other special charges | ---- | -88.33%7M | ---- | -97.64%3M | -69.39%60M | --17.63B | ---282M | 12,735.04%17.58B | -78.66%127M | 184.06%196M |
| Less:Write off | ---- | ---- | --0 | ---- | ---- | 24.01%909M | 690.43%909M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 182M | 100.00%42M | 10.35%-1.01B | -83.05%-767M | 104.96%21M | 52.66%-1.13B | 45.88%-802M | 306.43%514M | 47.03%-419M | -413.33%-423M |
| Income before tax | 16.09B | -46.52%15.4B | 18.16%98.59B | -32.55%26.77B | 1.38%28.79B | -52.08%83.44B | -80.46%5.13B | -82.25%10.23B | -23.67%39.69B | -25.83%28.4B |
| Income tax | 3.87B | 12.19%5.61B | -0.29%22.02B | -29.50%6.69B | -38.36%5B | -51.65%22.09B | -63.92%4.14B | -97.29%341M | -21.71%9.49B | -14.43%8.12B |
| Net income | 12.22B | -58.87%9.78B | 24.81%76.57B | -33.50%20.08B | 17.29%23.79B | -52.23%61.35B | -93.33%985M | -78.03%9.89B | -24.26%30.2B | -29.59%20.28B |
| Net income continuous operations | --12.22B | -58.87%9.78B | 24.81%76.57B | -33.50%20.08B | 17.29%23.79B | -52.23%61.35B | -93.32%986M | -78.03%9.89B | -24.26%30.2B | -29.59%20.28B |
| Noncontrolling interests | 78M | -102.00%-2M | 16.27%243M | 164.00%66M | 28.21%100M | -18.68%209M | -81.25%12M | 27.03%94M | -54.55%25M | 21.88%78M |
| Net income attributable to the company | 12.14B | -58.69%9.79B | 24.84%76.33B | -33.66%20.02B | 17.24%23.69B | -52.30%61.14B | -93.38%973M | -78.21%9.79B | -24.22%30.18B | -29.70%20.2B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.14B | -58.69%9.79B | 24.84%76.33B | -33.66%20.02B | 17.24%23.69B | -52.30%61.14B | -93.38%973M | -78.21%9.79B | -24.22%30.18B | -29.70%20.2B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 138.26 | -58.21%110.2 | 26.09%853.36 | -32.93%223.8 | 18.19%263.69 | -51.94%676.77 | -93.00%11.42 | -78.04%108.54 | -23.58%333.7 | -28.95%223.11 |
| Diluted earnings per share | 138.26 | -58.21%110.2 | 26.09%853.36 | -32.93%223.8 | 18.19%263.69 | -51.94%676.77 | -93.33%10.8152 | -78.07%108.4088 | -23.58%333.7 | -28.95%223.11 |
| Dividend per share | 0 | 0 | 8.42%309 | 8.42%154.5 | 0 | 9.40%285 | -0.35%142.5 | 0 | 21.28%142.5 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |